Abstract
To assess the effectiveness of ketorolac vs control for prevention of acute pseudophakic cystoid macular edema (CME). The following databases were searched: Medline (1950–June 11, 2011), The Cochrane Library (Issue 2, 2011), and the TRIP Database (up to 11 June 2011), using no language or other limits. Randomized controlled clinical trials (RCTs) were included that consisted of patients with acute pseudophakic cystoid macular edema, those comparing ketorolac with control, and those having at least a minimum follow-up of 28 days. In the four RCTs evaluating ketorolac vs control, treatment with ketorolac significantly reduced the risk of CME development at the end of treatment (∼4 weeks) compared to control (P=0.008; 95% confidence interval (0.03–0.58)). When analyzed individually, each individual study was statistically nonsignificant in its findings with the exception of one study. When the pooled relative risk was calculated, the large sample size of this systematic review led to overall statistical significance, which is attributable to the review's large sample size and not to the individual studies themselves. In this systematic review of four RCTs, two of which compared ketorolac with no treatment and two of which evaluated ketorolac vs placebo drops, treatment with ketorolac significantly reduced the risk of developing CME at the end of ∼4 weeks of treatment compared with controls. These results, however, should be interpreted with caution considering the paucity of large randomized clinical trials in the literature.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Loewenstein A, Zur D . Postsurgical cystoid macular edema. Dev Ophthalmol 2010; 47: 148–159.
Nishino M, Eguchi H, Iwata A, Shiota H, Tanaka M, Tanaka T . Are topical steroids essential after an uneventful cataract surgery? J Med Invest 2009; 56 (1–2): 11–15.
Guex-Crosier Y . The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 1999; 97 (3-4): 297–309.
Rossetti L, Chaudhuri J, Dickersin K . Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 1998; 105 (3): 397–405.
Gaynes BI, Fiscella R . Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf 2002; 25 (4): 233–250.
Perianin A, Roch-Arveiller M, Giroud JP, Hakim J . In vivo effects of indomethacin and flurbiprofen on the locomotion of neutrophils elicited by immune and non-immune inflammation in the rat. Eur J Pharmacol 1984; 106 (2): 327–333.
Guzek JP, Holm M, Cotter JB, Cameron JA, Rademaker WJ, Wissinger DH et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology 1987; 94 (5): 461–466.
Sivaprasad S, Bunce C, Wormald R . Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol 2005; 89 (11): 1420–1422.
Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M . A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 2008; 146 (4): 554–560.
Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T . Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 2006; 32 (9): 1474–1482.
Chatziralli IP, Papazisis L, Sergentanis TN . Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica 2011; 225 (2): 89–94.
Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg 2008; 34 (1): 64–69.
Flach AJ, Dolan BJ, Irvine AR . Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 1987; 103 (4): 479–486.
Flach AJ, Stegman RC, Graham J, Kruger LP . Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 1990; 97 (10): 1253–1258.
Rho DS . Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 2003; 29 (12): 2378–2384.
Dickersin K, Scherer R, Lefebvre C . Identifying relevant studies for systematic reviews. BMJ 1994; 309 (6964): 1286–1291.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1–12.
Higgins J, Green S . Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Section 6. The Cochrane Library, Issue 4 2006.
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL . Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003; 290 (7): 921–928.
Kaufman SR . Bias and sponsored research. Ophthalmology 2008; 115 (2): 412–413; author reply 413.
AAO. American Academy of Ophthalmology. Cataract in the Adult Eye, Preferred Practice Pattern. 2006. http://www.aao.org/ppp.
Flach AJ . The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998; 96: 557–634.
Acknowledgements
We would like to express our deepest gratitude to Robert A Honkanen, MD for his clinical insight in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yilmaz, T., Cordero-Coma, M. & Gallagher, M. Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. Eye 26, 252–258 (2012). https://doi.org/10.1038/eye.2011.296
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2011.296
Keywords
This article is cited by
-
The effect of topical ketorolac tromethamine on macular thickening after phacoemulsification in diabetic patients
BMC Ophthalmology (2023)
-
Combined phacoemulsification surgery and intravitreal triamcinolone injection versus stand-alone surgery in patients with type 2 diabetes: a prospective randomized trial
BMC Ophthalmology (2022)
-
Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: A double-masked placebo-controlled randomized clinical trial
Graefe's Archive for Clinical and Experimental Ophthalmology (2021)
-
The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis
Graefe's Archive for Clinical and Experimental Ophthalmology (2017)
-
Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine–Gass syndrome: a prospective case series
Eye (2016)
